person

Federico A.

Country
Italy
Department
Pneumology and Cystic Fibrosis Unit

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
43
Sites with multiple studies

Has run more than one trial at 43 of 82 partner sites.

Specializations

Respiratory Medicine

This investigator specializes in the treatment of cystic fibrosis, conducting extensive research into novel therapeutic approaches for managing this genetic condition. Their work focuses on evaluating innovative treatments that target the underlying causes of CF.

  • CFTR Modulator Therapies
  • Respiratory Function Assessment
  • Genetic Mutation Analysis

Their expertise extends to investigating both inhaled medications and systemic treatments for CF management.

Clinical Therapeutics

The investigator has developed particular expertise in combination therapy approaches, specifically studying multi-drug treatments for cystic fibrosis. Their research encompasses both single-agent and combination therapeutic strategies.

  • Drug Safety Evaluation
  • Therapeutic Efficacy Assessment
  • Long-term Treatment Outcomes

A significant focus is placed on evaluating novel therapeutic compounds and their effects on lung function improvement.

Personalized Medicine

The investigator's work includes research into rare CFTR mutations and personalized treatment approaches. They conduct studies examining patient-specific responses to various therapeutic interventions.

  • Mutation-specific Treatments
  • Biomarker Analysis
  • Treatment Response Prediction

Their research incorporates innovative techniques such as organoid response testing to predict treatment effectiveness.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.